Skip to content Skip to navigation

Neuroscience: Translate Application and Eligibility

We are pleased to announce Round 3 of Neuroscience:Translate, a grant program to support translational neuroscience research. The goal is to engage teams of researchers to address unmet needs in any area of neuroscience. The devices, diagnostic procedures, software, and pharmaceutical therapies that result from the work of funded teams are intended to lead to startup companies or be brought to the world through licensing agreements with existing companies.


Program:Wu Tsai Neurosciences Institute will provide funding to support collaborative translational research projects that involve co-principal investigators from diverse areas.

Award Amount: Up to $100,000 direct cost for one year

Deadline: October 16, 2020 at 11:59PM (Pacific Time)


Key Dates for 2021 Neuroscience: Translate Grants
Deadline for submitting Proposals October 16, 2020 at 11:59PM (Pacific Time)
Finalist presentations to the oversight committee December 2020
Notification of Awards December 2020 
Funding begins February 16, 2021
To Apply Submit one PDF file via email to Linda Lucian


Eligibility Criteria

Each proposal must have at least two co-principal investigators from two different fields both of whom must be members of the Wu Tsai Neurosciences Institute (become a faculty affiliate)

  • At least two fields should be represented. At least one faculty must be a clinician. Clinician is broadly defined to include faculty who work with human users, they don’t have to be humans with disease. The other faculty members may be from engineering, sciences or any other discipline.
  • All co-principal investigators must be Stanford faculty with UTL, MCL, CE, or NTL appointments.
  • Other team members (grad students, postdocs, research staff, etc.) may be included.
  • Intellectual property of core technology must be owned by Stanford (not under an option or license to any entity).

Selection Criteria

The research must relate directly to applications in neuroscience or brain health, broadly defined. The objectives of the project should include an outcome that will benefit patients or other users of the technology. Evaluation of proposals will be on the basis of innovation and scientific merit, potential impact, technical feasibility and the potential for translation, including commercialization. Award recipients will be required to prepare brief written quarterly progress reports and to present a mid-year project update to the Oversight Committee in September.


We encourage applicants to discuss their proposal with Program Director, Gordon Saul ( before submission. The proposal should follow the guidelines below.

Please submit one PDF file following the guidelines and required content listed below via email attachment to: Program Manager, Linda Lucian ( before 11:59 PM on October 16, 2020.

Submit file name as: Last name PI_Last name PI_2021WuTsaiNeuro

The Oversight Committee will review applications in early November and finalist will be invited to present in December 2020.  Applicants progressing to the finalist round will be invited to present to the Oversight Committee in the last week of November. The committee will review finalist presentations and make recommendations on funding priority, with funding to begin on February 16, 2021. Note that release of funds is dependent on appropriate review board approval (IRB, SRC, APLAC). Submission to review boards should occur prior to selection period in order to avoid delays should your proposal be selected for an award.

Application Materials

Full proposals should include:  

1)  Cover page: project title, names and contact information of the co-principal investigators, amount requested, and a one-paragraph summary

2)  Body of proposal: summary of the base technology, description of the product or service to be developed and translational plan of the milestones, timing, and cost to bring the product or service to market (further details below). 

The body of the grant proposal should not exceed 5 pages, excluding cover page, funding and pending proposal list, biosketch, references and budget. The body of proposal must include the following components (proposals will not be reviewed if any component is missing):

  • Importance of the project to neuro health, broadly defined; e.g., describe the need and envisioned product
  • Current technology status; offer test results or prototypes
  • Status of intellectual property; describe the IP strategy for this technology
  • Clinical need and market opportunity; include competing technologies and approaches
  • General commercial development plan; include a proposed regulatory pathway and the reimbursement/payment approach for this technology
  • Risk analysis statement for each: a) clinical need b) engineering/science feasibility c) intellectual property d) business/market
  • Expected specific milestones with work plan (per quarter)
  • Plan for follow on project funding post Neuroscience:Translate award

Also address or include the following:

  • Approvals for animal and human subjects should be sought ahead of the grant-funding period, in the proposal, include current review board status as ‘approved, protocol #  x ’, ‘submitted on xx/xx’ or letter of exemption
  • List of current funding related to this project, including internal seed grants obtained and pending proposals for each co-principal investigator
  • If the project has not already been disclosed to the Office of Technology Licensing (OTL), it is strongly recommended that an Invention and Technology Disclosure be submitted to OTL by the October 16, 2020 deadline. See the Inventor Disclosure page located on the OTL site.

3) Budget Page  (further details below)

Duration:Grants will be for a one-year period and may be submitted for renewal the following year. Renewal applications must have a comparison of milestones achieved vs. those planned in the original submission. Renewal applications will be evaluated on a competitive basis during the same review process as new applications. No Cost Extensions may be applied for by using the no cost extension request form.


Budgets:Grants may be requested for up to $100,000 direct cost for one year. Funds may be used for salary support of graduate students and other research staff, but may not be used for general staff or administrative support. Operating supplies, equipment items, prototyping expenses, imaging time and travel directly associated with the research activity are examples of eligible budget items. Budget details should include general categories such as personnel, supplies, travel, non-capital equipment and other project-related expenses. Submit using the Budget Page Template.

4)  Biosketch of co-principal investigators (not to exceed 5 pages each)

5)  Relevant literature references

Neuroscience:Translate Oversight Committee


Questions? Please contact Program Manager, Linda Lucian: